logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jen-Shi Chen

chang gung memorial hospital
H指数:44
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SLOG versus Modified FOLFIRINOX as First-Line Treatment for Advanced Pancreatic Cancer: A Randomized Phase II Trial (TCOG T5217)

SLOG与改良FOLFIRINOX作为晚期胰腺癌一线治疗的比较：一项随机II期临床试验（TCOG T5217）

European Journal of Cancer
IF7.1
2026-01-110
PRE
Nai-Jung Chiang; Yung-Yeh Su; I-Wei Ho; Li-Yuan Bai; Chung-Pin Li; Jen-Shi Chen; Chin-Fu Hsiao; Hsiao-Hui Tsou; Chiun Hsu; Tai-Jan Chiu; Yao-Yu Hsieh; Kun-Ming Rau; Ching-Liang Ho; Yan-Shen Shan; Li-Tzong Chen
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study

台湾地区胃肠胰神经内分泌新生物的临床结局：一项多中心登记研究—TCOG T1214研究

Cancer
IF5.1
2025-08-200
OAAI
Hui-Jen Tsai MD PhD; Ming-Huang Chen MD PhD; Hsiu-Po Wang MD; Chin-Fu Hsiao PhD; Yen-Yang Chen MD PhD; Jen-Shi Chen MD; Mei-Due Yang MD PhD; Chin-Yuan Tzen MD PhD; Yan-Shen Shan MD PhD; Li-Yaun Bai MD PhD; De-Chuan Chan MD; Pei-Yi Chu MD PhD; Ching-Liang Ho MD; Youngsen Yang MD; Johnson Lin MD; Hsuan-Yu Lin MD; Cheng-Shyong Chang MD; Chuan-Cheng Wang MD; Tsann-Long Hwang MD; Li-Tzong Chen MD PhD
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial

Nivolumab联合化疗治疗HER2-negative，既往未治疗，不可切除，晚期或复发性胃/胃食管交界癌患者: 吸引-4随机，双盲，安慰剂对照，3期临床试验的3年随访

GASTRIC CANCER
IF5.1
2024-08-201
OAAI
Boku, Narikazu; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Yamaguchi, Kensei; Kato, Ken; Kadowaki, Shigenori; Tsuji, Kunihiro; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Chung, Ik-Joo; Sym, Sun Jin; Chen, Li-Tzong; Chen, Jen-Shi; Bai, Li-Yuan; Nakada, Takashi; Hagihara, Shunsuke; Makino, Reina; Nishiyama, Eiji; Kang, Yoon-Koo
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2024-08-0115
PRE
Oh, Do-Youn; He, Aiwu Ruth; Bouattour, Mohamed; Okusaka, Takuji; Qin, Shukui; Chen, Li-Tzong; Kitano, Masayuki; Lee, Choong-kun; Kim, Jin Won; Chen, Ming -Huang; Suksombooncharoen, Thatthan; Ikeda, Masafumi; Lee, Myung Ah; Chen, Jen-Shi; Potemski, Piotr; Burris, Howard A.; Ostwal, Vikas; Tanasanvimon, Suebpong; Morizane, Chigusa; Zaucha, Renata E.; Mcnamara, Mairead G.; Avallone, Antonio; Cundom, Juan E.; Breder, Valeriy; Tan, Benjamin; Shimizu, Satoshi; Tougeron, David; Evesque, Ludovic; Petrova, Mila; Zhen, David B.; Gillmore, Roopinder; Gupta, Vineet Govinda; Dayyani, Farshid; Park, Joon Oh; Buchschacher Jr, Gary L.; Rey, Felipe; Kim, Hyosung; Wang, Julie; Morgan, Claire; Rokutanda, Nana; Zotkiewicz, Magdalena; Vogel, Arndt; Valle, Juan W.
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
FUTURE ONCOLOGY
IF2.6
2023-09-257
OA
Oh, Do-Youn; He, Aiwu Ruth; Qin, Shukui; Chen, Li-Tzong; Okusaka, Takuji; Vogel, Arndt; Kim, Jin Won; Suksombooncharoen, Thatthan; Lee, Myung Ah; Kitano, Masayuki; Burris, Howard; Bouattour, Mohamed; Tanasanvimon, Suebpong; McNamara, Mairead G.; Zaucha, Renata; Avallone, Antonio; Tan, Benjamin; Cundom, Juan; Lee, Choong-kun; Takahashi, Hidenori; Ikeda, Masafumi; Chen, Jen-Shi; Wang, Julie; Makowsky, Mallory; Rokutanda, Nana; Zotkiewicz, Magdalena; Kurland, John F.; Cohen, Gordon; Valle, Juan W.
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized Study
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2023-09-013
PRE
Chiu, Yen-Feng; Liu, Tsang-Wu; Shan, Yan-Shen; Chen, Jen-Shi; Li, Chung-Pin; Ho, Ching-Liang; Hsieh, Ruey-Kuen; Hwang, Tsann-Long; Chen, Li-Tzong; Chang, Hui-Ju

研究方向

暂未获取到该数据
W
Wen‐Chi Chou
H 指数:32论文数:323被引数:4,390
S
Siew Tzuh Tang
H 指数:38论文数:164被引数:4,722
W
Wen‐Cheng Chang
H 指数:26论文数:90被引数:2,015
F
Fur‐Hsing Wen
H 指数:21论文数:89被引数:1,250
L
Li‐Tzong Chen
H 指数:55论文数:538被引数:1.7万
C
Chia‐Hsun Hsieh
H 指数:19论文数:106被引数:1,082
C
Chia‐Hsun Hsieh
H 指数:32论文数:217被引数:3,488
Y
Yan‐Shen Shan
H 指数:41论文数:374被引数:7,507
M
Ming‐Mo Hou
H 指数:19论文数:102被引数:1,573
W
Wen‐Chi Shen
H 指数:14论文数:79被引数:648